Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaleb Michaud

Showing results (91-100 of 273) with videos related to

Pageof 28
Sort By:
Arthritis Care & Research|July 11, 2023
Urban and Rural Patterns of Health Care Utilization Among People With Rheumatoid Arthritis and Osteoarthritis in a Large US Patient RegistryLuke W Desilet, Sofia Pedro, Patricia Katz, et al.
RMD Open|July 1, 2021
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, et al.
Arthritis and Rheumatism|December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
The Journal of Rheumatology|February 5, 2004
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practiceFrederick Wolfe, Kaleb Michaud, Thomas A Burke, et al.
Arthritis Research & Therapy|October 20, 2011
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effectsChristopher J Smith, Harlan Sayles, Ted R Mikuls, et al.
ACR Open Rheumatology|October 9, 2024
The Burden of Glucocorticoids: Patterns of Use, Adverse Health Conditions, and Health Care Use in Two Cohorts With Systemic Lupus ErythematosusPatricia Katz, Sofia Pedro, Joonsuk Park, et al.
ACR Open Rheumatology|February 20, 2021
The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)Patricia Katz, Sofia Pedro, Laura Trupin, et al.
Arthritis and Rheumatism|August 6, 2005
Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritisSaralynn Allaire, Frederick Wolfe, Jingbo Niu, et al.
Arthritis Care & Research|February 4, 2022
Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid ArthritisGulsen Ozen, Sophie Dell'Aniello, Sofia Pedro, et al.
Arthritis Care & Research|March 31, 2021
Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational StudyKaleb Michaud, Sofia Pedro, Kristin Wipfler, et al.
Pageof 28

Showing results (91-100 of 273) with videos related to

Sort By:
Pageof 28
Arthritis Care & Research|July 11, 2023
Urban and Rural Patterns of Health Care Utilization Among People With Rheumatoid Arthritis and Osteoarthritis in a Large US Patient RegistryLuke W Desilet, Sofia Pedro, Patricia Katz, et al.
RMD Open|July 1, 2021
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, et al.
Arthritis and Rheumatism|December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
The Journal of Rheumatology|February 5, 2004
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practiceFrederick Wolfe, Kaleb Michaud, Thomas A Burke, et al.
Arthritis Research & Therapy|October 20, 2011
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effectsChristopher J Smith, Harlan Sayles, Ted R Mikuls, et al.
ACR Open Rheumatology|October 9, 2024
The Burden of Glucocorticoids: Patterns of Use, Adverse Health Conditions, and Health Care Use in Two Cohorts With Systemic Lupus ErythematosusPatricia Katz, Sofia Pedro, Joonsuk Park, et al.
ACR Open Rheumatology|February 20, 2021
The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)Patricia Katz, Sofia Pedro, Laura Trupin, et al.
Arthritis and Rheumatism|August 6, 2005
Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritisSaralynn Allaire, Frederick Wolfe, Jingbo Niu, et al.
Arthritis Care & Research|February 4, 2022
Reduction of Cardiovascular Disease and Mortality Versus Risk of New-Onset Diabetes Mellitus With Statin Use in Patients With Rheumatoid ArthritisGulsen Ozen, Sophie Dell'Aniello, Sofia Pedro, et al.
Arthritis Care & Research|March 31, 2021
Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational StudyKaleb Michaud, Sofia Pedro, Kristin Wipfler, et al.
Pageof 28